Live News EQUITY FLASH L impact Oct 30, 2026, 12:56 PM UTC KeyBanc Raises ResMed Price Target to $277 From $267 KeyBanc maintained ResMed at Overweight, according to Benzinga. RMD SquawkNews Desk